Loading...
Givaudan S.A.
0QPS.L•LSE
Basic Materials
Chemicals - Specialty
£3293.00
£10.30(0.31%)
Givaudan S.A. (0QPS.L) Financial Performance & Statements
Review Givaudan S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
7.19%
↑ 7.19%
Operating Income Growth
24.91%
↑ 24.91%
Net Income Growth
22.06%
↑ 22.06%
Operating Cash Flow Growth
18.35%
↑ 18.35%
Operating Margin
18.82%
↑ 18.82%
Gross Margin
43.17%
↑ 43.17%
Net Profit Margin
14.71%
↑ 14.71%
ROE
24.52%
↑ 24.52%
ROIC
15.06%
↑ 15.06%
Givaudan S.A. (0QPS.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Givaudan S.A. stock.
Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
---|---|---|---|---|
Revenue | $3.74B | $3.38B | $3.54B | $3.46B |
Cost of Revenue | $2.09B | $2.05B | $2.15B | $2.22B |
Gross Profit | $1.65B | $1.33B | $1.39B | $1.24B |
Gross Profit Ratio | $0.44 | $0.39 | $0.39 | $0.36 |
R&D Expenses | $280.00M | $242.00M | $244.00M | $236.00M |
SG&A Expenses | $589.00M | $515.00M | $513.00M | $523.00M |
Operating Expenses | $917.00M | $796.00M | $807.00M | $774.00M |
Total Costs & Expenses | $3.008B | $2.85B | $2.95B | $3.00B |
Interest Income | $17.00M | $5.00M | $3.00M | $6.00M |
Interest Expense | $56.00M | $56.00M | $58.00M | $49.00M |
Depreciation & Amortization | $173.00M | $179.00M | $177.00M | $179.00M |
EBITDA | $902.00M | $706.00M | $759.00M | $644.00M |
EBITDA Ratio | $0.24 | $0.21 | $0.21 | $0.19 |
Operating Income | $729.00M | $535.00M | $581.00M | $470.00M |
Operating Income Ratio | $0.20 | $0.16 | $0.16 | $0.14 |
Other Income/Expenses (Net) | -$29.00M | -$64.00M | -$68.00M | -$65.00M |
Income Before Tax | $700.00M | $471.00M | $513.00M | $416.00M |
Income Before Tax Ratio | $0.19 | $0.14 | $0.15 | $0.12 |
Income Tax Expense | $112.00M | $29.00M | $67.00M | $0.00 |
Net Income | $588.00M | $444.00M | $449.00M | $416.00M |
Net Income Ratio | $0.16 | $0.13 | $0.13 | $0.12 |
EPS | $63.76 | $48.12 | $48.69 | $45.09 |
Diluted EPS | $63.50 | $47.95 | $48.53 | $44.99 |
Weighted Avg Shares Outstanding | $9.22M | $9.23M | $9.22M | $9.23M |
Weighted Avg Shares Outstanding (Diluted) | $9.26M | $9.26M | $9.25M | $9.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan